Admetsys PrecisionOne Automated Glycemic Control System Gets CE Mark
The PrecisionOne system functions as a metabolic autopilot, providing automated glucose regulation and real-time analysis of blood chemistry values for critical care patients.
Category: Diabetes & Metabolic Diseases
Diabetes & Metabolic Diseases
Latest
Diabetes & Metabolic Diseases
LatestThe Portland Diabetes Protocols
A finely tuned set of orders for intravenous insulin infusions in hospitalized diabetic patients, the Portland Diabetes Protocols have been successfully used at institutions throughout the world to control hyperglycemia.
Diabetes & Metabolic Diseases
PopularCarolina Liquid Chemistries, GlycoMark Partner for New Diabetes Management Test
Carolina Liquid Chemistries Corp will market the GlycoMark blood test as one of a complete range of diabetes assays for the BioLis 24i bench top chemistry analyzer.
Point-of-Care Test Detects Early-Stage Diabetes Complications
The NC-stat DPNCheck from NeuroMetrix is a rapid, quantitative test designed to detect diabetic peripheral neuropathy early enough to allow physicians to select appropriate treatment.
Read More
HbA1c Test Receives FDA Clearance
Abbott Laboratories has received 510(k) clearance for the Architect Clinical Chemistry Hemoglobin A1c test, a tool to aid physicians in diagnosing and monitoring diabetes.
Read More
National Diabetes Coalition Advises Caution on New Population Survey
Asian Americans at risk for obesity related disorders.
Read More
Diabetes Tests Oft Times Not Being Ordered or Used Properly
A study suggests improved communication is needed between the lab and the clinician on when to follow up with a patient who has a significant change in HbA1c.
Read More
Atherotech Adds Trio of Genetic Tests to Cardiometabolic Test Menu
Warfarin, Plavix sensitivity tests, and thrombophilia risk test provide personalized risk assessment, diagnosis, and treatment.
Read More
Mexican American Youth Show Sighs of Metabolic Syndrome: Early Screening Critical to Reduce Risk of Future Diabetes, Heart Disease
The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
Read More
FDA Approves First A1c Test Labeled for Diagnosing Diabetes
The HbA1c tests, or A1c tests, currently on the market are FDA-cleared for monitoring a patient’s blood glucose control, but not for diagnosing diabetes, says the FDA.
Read More
Panel Backs Status Quo, Two-Step Diagnostic Approach for Gestational Diabetes Mellitus
While many other countries and respected organizations support a one-step approach for testing pregnant women, the NIH urges adhering to a two-step approach until it is shown to be less advantageous.
Read MoreIndependent Panel to Present Findings on Diagnosing Gestational Diabetes Mellitus
To better understand the benefits and risks of various screening and diagnostic approaches, the NIH is convening a Consensus Development Conference from October 29 to 31 to assess the available scientific evidence.
Read More
HbA1c for Diabetes Testing Not Yet Universal
Using glycated albumin together with HbA1c, we can make the next positive step in providing better care for all people with diabetes
Read MoreJoslin Diabetes Center Identifies Markers Which Predict Renal Failure Risk
Scientists have identified two novel markers that, when elevated in the blood stream, can predict accurately the risk of renal failure in patients with Type 1 and Type 2 diabetes.
Read More
Diabetes: Testing, Monitoring, Stemming the Rising Tide?
Testing options are growing with the proliferation of HbA1c.
Read MoreMcKesson Awards $1.3 Million To Diabetes Researchers
The grants will support studies on diabetes care and management at six esteemed US institutions.
Read MorePregnant Women Not Being Adequately Screened for Gestational Diabetes Mellitus
Nearly one third of pregnant women are not being screened by a simple laboratory test for gestational diabetes mellitus (gestational diabetes).
Read MoreDiazyme Cleared to Market SMART HbA1c Assay for Diabetes Monitoring
Diazyme Laboratories announced today that the FDA has granted Diazyme 510(k) clearance to market its SMART HbA1c Assay on its new SMART Point of Care System for diabetes monitoring.
Read More